title: [Scleromyxedema therapy with isotretinoin].
abstract: We report on a 56-year-old male patient suffering from scleromyxedema, who was successfully treated with isotretinoin (13-cis retinoic acid, Roaccutan). After 10 months therapy, we observed considerable reduction of the cutaneous infiltration and the skin thickening; the papular eruptions had almost completely disappeared. The mobility of the joints, however, could only be slightly improved.
authors.affiliation: Universitäts-Hautklinik und Poliklinik, der Rheinischen Friedrich-Wilhelm-Universität Bonn.
authors.forename: K
authors.initials: K
authors.lastname: Lominska-Lasota
authors.forename: G
authors.initials: G
authors.lastname: Rosen-Uzelac
authors.forename: W
authors.initials: W
authors.lastname: Reichl
authors.forename: R
authors.initials: R
authors.lastname: Bauer
mesh_terms: D004334:Drug Administration Schedule; D006801:Humans; D015474:Isotretinoin; D008297:Male; D008875:Middle Aged; D009230:Myxedema / Q000188:drug therapy* / Q000473:pathology; D012594:Scleroderma, Localized / Q000188:drug therapy* / Q000473:pathology; D012867:Skin / Q000473:pathology; D014212:Tretinoin / Q000008:administration & dosage*
chemical_list: D014212:Tretinoin; D015474:Isotretinoin
vernacular_title: Skleromyxödem-Therapie mit Isotretinoin.